Pancreatic cancer is one of the deadliest cancers worldwide, with a five-year survival rate of 13%. This poor prognosis stems ...

Researchers have discovered race-associated molecular differences in tumors that may impact the way patients with pancreatic ...

A new study from Memorial Sloan Kettering Cancer Center has shown that an RNA-based neoantigen vaccine can generate ...

Pancreatic cancer’s deadly resilience may be tied to extrachromosomal DNA, which allows tumor cells to rapidly adapt to ...

A novel, rapid blood test demonstrated potential for detecting early-stage pancreatic cancer, according to results of a ...

Fatty pancreas disease, characterized by intra-pancreatic fat deposition, is more prevalent than diabetes, pancreatitis, and ...

Understanding your tumor biology is key to finding the right treatment for pancreatic cancer. Identifying mutations, or changes in a [...] READ MORE ...

Pifani has lost several family members to pancreatic cancer — including a cousin and uncle who both died in six months or less — so he feels “extremely fortunate.” The family has a genetic mutation ...

This month’s Research Spotlight highlights significant advancements in pancreatic cancer research and patient support.

Pancreatic cancer is one of the deadliest cancers worldwide, with a five-year survival rate of 13%. This poor prognosis stems from both late detection ...

A study published last month in Nature underscores the potential for a new personalized pancreatic cancer vaccine to keep the ...

In the seriously great news department, pancreatic cancer is expected to pass colorectal cancer as the second biggest cause ...